Rightslink® by Copyright Clearance Center

Prognostic value of circulating tumor DNA at diagnosis and its early decrease after one cycle of neoadjuvant chemotherapy for patients with advanced epithelial ovarian cancer. An ancillary analysis of the CHIVA phase II GINECO trial

Author:

Henri Azaïs,Camille Brochard,Valérie Taly,Louise Benoit,Gwenaël Ferron,Isabelle Ray-Coquard,Benoit You,Sophie Abadie-Lacourtoisie,Coriolan Lebreton,Laurence Venat,Christophe Louvet,Laure Favier,Cyriac Blonz,Nadine Dohollou,Emmanuelle Malaurie et al.

Publication:

Gynecologic Oncology

Publisher:

Elsevier

Date:

January 2025

Please select your organization and/or account

Organization

Account

Please select your account from the above dropdown list. These accounts represent the offices, campuses, and other sites where your organization operates. Your account selection should match where you typically have an office or workspace. Even when you are traveling or temporarily working elsewhere, you should select the account that represents where you customarily work.

Cancel OK

Creative Commons

This is an open access article distributed under the terms of the Creative Commons CC-BY license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article.